Arenavirus evasion of host anti-viral responses

Viruses

Volumn 4, Issue 10, 2012, Pages 2182-2196

  Hayes, Melissa ^a   Salvato, Maria ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Arenavirus; Immune evasion; Innate immune response; TLR2

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARENAVIRUS; ARENAVIRUS INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRESS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; IMMUNOSENSOR; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INFLAMMATION; INNATE IMMUNITY; LASSA VIRUS; LASSA VIRUS INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION; MICROBIAL ACTIVITY; MIXED INFECTION; NONHUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STRAIN DIFFERENCE; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS SURVIVAL; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODY FORMATION; ARENAVIRIDAE INFECTIONS; ARENAVIRUS; CYTOKINES; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERFERON TYPE I; MYELOID DIFFERENTIATION FACTOR 88; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; VIRUS REPLICATION;

ANIMALIA; ARENAVIRUS;

EID: 84868104378     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4102182     Document Type: Review

References (52)

1. Biron, C.A.; Nguyen, K.B.; Pien, G.C. Innate immune responses to LCMV infections: Natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 2002, 263, 7-27.
2. Merigan, T.C.; Oldstone, M.B.; Welsh, R.M. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 1977, 268, 67-68.
3. Djavani, M.M.; Crasta, O.R.; Zapata, J.C.; Fei, Z.; Folkerts, O.; Sobral, B.; Swindells, M.; Bryant, J.; Davis, H.; Pauza, C.D.; et al. Early blood profiles of virus infection in a monkey model for lassa fever. J. Virol. 2007, 81, 7960-7973.
4. Rodas, J.D.; Cairo, C.; Djavani, M.; Zapata, J.C.; Ruckwardt, T.; Bryant, J.; Pauza, C.D.; Lukashevich, I.S.; Salvato, M.S. Circulating natural killer and gammadelta t cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus. Mem. Inst. Oswaldo. Cruz. 2009, 104, 583-591.
5. Asper, M.; Sternsdorf, T.; Hass, M.; Drosten, C.; Rhode, A.; Schmitz, H.; Gunther, S. Inhibition of different lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 2004, 78, 3162-3169.
6. Habjan, M.; Andersson, I.; Klingstrom, J.; Schumann, M.; Martin, A.; Zimmermann, P.; Wagner, V.; Pichlmair, A.; Schneider, U.; Muhlberger, E.; et al. Processing of genome 5' termini as a strategy of negative-strand rna viruses to avoid rig-i-dependent interferon induction. PLoS One 2008, 3, e2032.
7. Pannetier, D.; Faure, C.; Georges-Courbot, M.C.; Deubel, V.; Baize, S. Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to mopeia virus infection. J. Virol. 2004, 78, 10516-10524.
8. Sakuma, T.; Noda, T.; Urata, S.; Kawaoka, Y.; Yasuda, J. Inhibition of lassa and marburg virus production by tetherin. J. Virol. 2009, 83, 2382-2385.
9. Zhou, S.; Cerny, A.M.; Zacharia, A.; Fitzgerald, K.A.; Kurt-Jones, E.A.; Finberg, R.W. Induction and inhibition of type i interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 2010, 84, 9452-9462.
10. Jung, A.; Kato, H.; Kumagai, Y.; Kumar, H.; Kawai, T.; Takeuchi, O.; Akira, S. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic t-cell response via myd88. J. Virol. 2008, 82, 196-206.
11. Camus, G.S.; Qui, X.; Bente, D.A.; Strong, U.C.; Jones, S.M. Resistance to a Lassa virus infection is interferon-dependent, but not B or T cell-mediated in mice. Abstracts for the 28th Meeting of the American Society for Virology 2009, W7-7, 94.
12. Mahanty, S.; Bausch, D.G.; Thomas, R.L.; Goba, A.; Bah, A.; Peters, C.J.; Rollin, P.E. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute lassa fever. J. Infect. Dis. 2001, 183, 1713-1721.
13. Ben-Baruch, A.; Michiel, D.F.; Oppenheim, J.J. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 1995, 270, 11703-11706.
14. Lukashevich, I.S.; Maryankova, R.; Vladyko, A.S.; Nashkevich, N.; Koleda, S.; Djavani, M.; Horejsh, D.; Voitenok, N.N.; Salvato, M.S. Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on il-8 and tnf-alpha gene expression. J. Med. Virol. 1999, 59, 552-560.
15. Fennewald, S.M.; Aronson, J.F.; Zhang, L.; Herzog, N.K. Alterations in nf-kappab and rbp-jkappa by arenavirus infection of macrophages in vitro and in vivo. J. Virol. 2002, 76, 1154-1162.
16. Fennewald, S.M.; Scott, E.P.; Zhang, L.; Yang, X.; Aronson, J.F.; Gorenstein, D.G.; Luxon, B.A.; Shope, R.E.; Beasley, D.W.; Barrett, A.D.; et al. Thioaptamer decoy targeting of ap-1 proteins influences cytokine expression and the outcome of arenavirus infections. J. Gen. Virol. 2007, 88, 981-990.
17. Zhou, S.; Kurt-Jones, E.A.; Mandell, L.; Cerny, A.; Chan, M.; Golenbock, D.T.; Finberg, R.W. Myd88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 2005, 35, 822-830.
18. Barbalat, R.; Lau, L.; Locksley, R.M.; Barton, G.M. Toll-like receptor 2 on inflammatory monocytes induces type i interferon in response to viral but not bacterial ligands. Nat. Immunol. 2009, 10, 1200-1207.
19. Zhou, S.; Halle, A.; Kurt-Jones, E.A.; Cerny, A.M.; Porpiglia, E.; Rogers, M.; Golenbock, D.T.; Finberg, R.W. Lymphocytic choriomeningitis virus (LCMV) infection of cns glial cells results in tlr2-myd88/mal-dependent inflammatory responses. J. Neuroimmunol. 2008, 194, 70-82.
20. Hayes, M.W.; Carrion, R., Jr.; Nunneley, J.; Medvedev, A.E.; Salvato, M.S.; Lukashevich, I.S. Pathogenic old world arenaviruses inhibit tlr2/mal-dependent proinflammatory cytokines in vitro. J. Virol. 2012, 86, 7216-7226.
21. Fisher-Hoch, S.P.; McCormick, J.B. Towards a human lassa fever vaccine. Rev. Med. Virol. 2001, 11, 331-341.
22. ter Meulen, J.; Badusche, M.; Kuhnt, K.; Doetze, A.; Satoguina, J.; Marti, T.; Loeliger, C.; Koulemou, K.; Koivogui, L.; Schmitz, H.; et al. Characterization of human cd4(+) t-cell clones recognizing conserved and variable epitopes of the lassa virus nucleoprotein. J. Virol. 2000, 74, 2186-2192.
23. Meulen, J.; Badusche, M.; Satoguina, J.; Strecker, T.; Lenz, O.; Loeliger, C.; Sakho, M.; Koulemou, K.; Koivogui, L.; Hoerauf, A. Old and new world arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by lassa virus-specific human cd4+ t-cell clones. Virology 2004, 321, 134-143.
24. Zhou, S.; Kurt-Jones, E.A.; Cerny, A.M.; Chan, M.; Bronson, R.T.; Finberg, R.W. Myd88 intrinsically regulates cd4 t-cell responses. J. Virol. 2009, 83, 1625-1634.
25. Bartholdy, C.; Christensen, J.E.; Grujic, M.; Christensen, J.P.; Thomsen, A.R. T-cell intrinsic expression of myd88 is required for sustained expansion of the virus-specific cd8+ t-cell population in lcmv-infected mice. J. Gen. Virol. 2009, 90, 423-431.
26. Rahman, A.H.; Cui, W.; Larosa, D.F.; Taylor, D.K.; Zhang, J.; Goldstein, D.R.; Wherry, E.J.; Kaech, S.M.; Turka, L.A. Myd88 plays a critical t cell-intrinsic role in supporting cd8 t cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 2008, 181, 3804-3810.
27. Rahman, A.H.; Zhang, R.; Blosser, C.D.; Hou, B.; Defranco, A.L.; Maltzman, J.S.; Wherry, E.J.; Turka, L.A. Antiviral memory cd8 t-cell differentiation, maintenance, and secondary expansion occur independently of myd88. Blood 2011, 117, 3123-3130.
28. Johnson, K.M.; McCormick, J.B.; Webb, P.A.; Smith, E.S.; Elliott, L.H.; King, I.J. Clinical virology of lassa fever in hospitalized patients. J. Infect. Dis. 1987, 155, 456-464.
29. McCormick, J.B.; Fisher-Hoch, S.P. Lassa fever. Curr. Top. Microbiol. Immunol. 2002, 262, 75-109.
30. Moraz, M.L.; Kunz, S. Pathogenesis of arenavirus hemorrhagic fevers. Expert. Rev. Anti Infect. Ther. 2011, 9, 49-59.
31. Lukashevich, I.S.; Tikhonov, I.; Rodas, J.D.; Zapata, J.C.; Yang, Y.; Djavani, M.; Salvato, M.S. Arenavirus-mediated liver pathology: Acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol. 2003, 77, 1727-1737.
32. Lukashevich, I.S.; Rodas, J.D.; Tikhonov, II; Zapata, J.C.; Yang, Y.; Djavani, M.; Salvato, M.S. Lcmv-mediated hepatitis in rhesus macaques: We but not arm strain activates hepatocytes and induces liver regeneration. Arch. Virol. 2004, 149, 2319-2336.
33. Zapata, J.; While, D.; Poonia, B.; Mani, S.; Jett, M.; Carrion, R., Jr.; Crasta, O.; Zhang, Y.; Salvato, M.; Lukashevich, I. Expression of coagulation factor thrombomodulin is increased in cells exposed to lassa virus. In Proceedings of The 29th ASV Meeting, Bozeman, Montana, USA, July 17, 2010.
34. Baize, S.; Pannetier, D.; Faure, C.; Marianneau, P.; Marendat, I.; Georges-Courbot, M.C.; Deubel, V., Role of interferons in the control of lassa virus replication in human dendritic cells and macrophages. Microbes. Infect. 2006, 8, 1194-1202.
35. Martinez-Sobrido, L.; Emonet, S.; Giannakas, P.; Cubitt, B.; Garcia-Sastre, A.; de la Torre, J.C. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 2009, 83, 11330-11340.
36. Martinez-Sobrido, L.; Giannakas, P.; Cubitt, B.; Garcia-Sastre, A.; de la Torre, J.C. Differential inhibition of type i interferon induction by arenavirus nucleoproteins. J. Virol. 2007, 81, 12696-12703.
37. Martinez-Sobrido, L.; Zuniga, E.I.; Rosario, D.; Garcia-Sastre, A.; de la Torre, J.C. Inhibition of the type i interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 2006, 80, 9192-9199.
38. Pannetier, D.; Reynard, S.; Russier, M.; Journeaux, A.; Tordo, N.; Deubel, V.; Baize, S. Human dendritic cells infected with the nonpathogenic mopeia virus induce stronger t-cell responses than those infected with lassa virus. J. Virol. 2011, 85, 8293-8306.
39. Baize, S.; Kaplon, J.; Faure, C.; Pannetier, D.; Georges-Courbot, M.C.; Deubel, V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 2004, 172, 2861-2869.
40. Sevilla, N.; Kunz, S.; Holz, A.; Lewicki, H.; Homann, D.; Yamada, H.; Campbell, K.P.; de La Torre, J.C.; Oldstone, M.B. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 2000, 192, 1249-1260.
41. Baize, S.; Marianneau, P.; Loth, P.; Reynard, S.; Journeaux, A.; Chevallier, M.; Tordo, N.; Deubel, V.; Contamin, H. Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J. Virol. 2009, 83, 5890-5903.
42. Borrow, P.; Evans, C.F.; Oldstone, M.B. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 1995, 69, 1059-1070.
43. Sevilla, N.; McGavern, D.B.; Teng, C.; Kunz, S.; Oldstone, M.B. Viral targeting of hematopoietic progenitors and inhibition of dc maturation as a dual strategy for immune subversion. J. Clin. Inv. 2004, 113, 737-745.
44. Mahanty, S.; Hutchinson, K.; Agarwal, S.; McRae, M.; Rollin, P.E.; Pulendran, B. Cutting edge: Impairment of dendritic cells and adaptive immunity by ebola and lassa viruses. J. Immunol. 2003, 170, 2797-2801.
45. Cuevas, C.D.; Lavanya, M.; Wang, E.; Ross, S.R. Junin virus infects mouse cells and induces innate immune responses. J. Virol. 2011, 85, 11058-11068.
46. Groseth, A.; Hoenen, T.; Weber, M.; Wolff, S.; Herwig, A.; Kaufmann, A.; Becker, S. Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl. Trop. Dis. 2011, 5, e1137.
47. Bieback, K.; Lien, E.; Klagge, I.M.; Avota, E.; Schneider-Schaulies, J.; Duprex, W.P.; Wagner, H.; Kirschning, C.J.; Ter Meulen, V.; Schneider-Schaulies, S. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 2002, 76, 8729-8736.
48. Boehme, K.W.; Guerrero, M.; Compton, T. Human cytomegalovirus envelope glycoproteins b and h are necessary for tlr2 activation in permissive cells. J. Immunol. 2006, 177, 7094-7102.
49. Chang, S.; Dolganiuc, A.; Szabo, G. Toll-like receptors 1 and 6 are involved in tlr2-mediated macrophage activation by hepatitis c virus core and ns3 proteins. J. Leukoc. Biol. 2007, 82, 479-487.
50. Dolganiuc, A.; Oak, S.; Kodys, K.; Golenbock, D.T.; Finberg, R.W.; Kurt-Jones, E.; Szabo, G. Hepatitis c core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004, 127, 1513-1524.
51. Sirisinha, S. Insight into the mechanisms regulating immune homeostasis in health and disease. Asian Pac. J. Allergy Immunol. 2011, 29, 1-14.
52. Kirschning, C.J.; Dreher, S.; Maass, B.; Fichte, S.; Schade, J.; Koster, M.; Noack, A.; Lindenmaier, W.; Wagner, H.; Boldicke, T. Generation of anti-tlr2 intrabody mediating inhibition of macrophage surface tlr2 expression and tlr2-driven cell activation. BMC Biotechnol. 2010, 10, 31.